KMNO / USDC

KMNO / USDT

TST / USDT

TST / USDC

TST / TRY

EIGEN / TRY

EIGEN / USDT

EIGEN / USDC

EIGEN / BTC

EIGEN / FDUSD

SLF / BTC

SLF / USDC

SLF / USDT

SLF / TRY

SAHARA / BNB

OG / TRY

OG / USDT

OG / BTC

RVN / BTC

MITO / BNB

URBAN COMPANY LIMITED

QMS MEDI LTD

SMARTEN POWER SYSTEMS LTD

TRF LIMITED

SUPERHOUSE LIMITED

IRM ENERGY LIMITED

BRAND CONCEPTS LIMITED

N R VANDANA TEX IND LTD

ANLON HEALTHCARE LIMITED

PROZONE REALTY LIMITED

DE NEERS TOOLS LIMITED

HAPPY SQUARE OUTSOURC S L

ENFUSE SOLUTIONS LIMITED

SHRADHA INFRAPROJECTS LTD

MANGAL ELECTRICAL IND L

SHARP CHUCKS N MACHINES L

ZODIAC CLOTHING CO. LTD.

NAGREEKA EXPORTS LTD.

SHREE RAMA NEWSPRINT LTD

SARVESHWAR FOODS LIMITED

Click here to get full coverage on Praxis Solutions Expands Leadership Team, Appoints Charlie Shaffer as Chief Revenue Officer to Lead Distribution Growth and AI-Powered Transformation - PR Newswire

Praxis Solutions Expands Leadership Team, Appoints Charlie Shaffer as Chief Revenue Officer to Lead Distribution Growth and AI-Powered Transformation  PR Newswire

Praxis Solutions Expands Leadership Team, Appoints Charlie Shaffer as Chief Revenue Officer to Lead Distribution Growth and AI-Powered Transformation - PR Newswire

Click here to get full coverage on Praxis Precision initiated with a Buy at JonesResearch - TipRanks

Praxis Precision initiated with a Buy at JonesResearch  TipRanks

Praxis Precision initiated with a Buy at JonesResearch - TipRanks

Click here to get full coverage on PRAXIS ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire

PRAXIS ALERT: Bragar Eagel & Squire, P.C. is Investigating  GlobeNewswire

PRAXIS ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire

Click here to get full coverage on Praxis Zoom Event: Martin Bernstein on the Economics of the Financial Sector - Sonoma Sun

Praxis Zoom Event: Martin Bernstein on the Economics of the Financial Sector  Sonoma Sun

Praxis Zoom Event: Martin Bernstein on the Economics of the Financial Sector - Sonoma Sun

Click here to get full coverage on Theme Panel: The Political Ethics and Praxis of Liberation - - Political Science Now

Theme Panel: The Political Ethics and Praxis of Liberation -  Political Science Now

Theme Panel: The Political Ethics and Praxis of Liberation - - Political Science Now

Click here to get full coverage on Standardized Test Requirements – Center For Student Success And Educator Excellence - Montclair State University

Standardized Test Requirements – Center For Student Success And Educator Excellence  Montclair State University

Standardized Test Requirements – Center For Student Success And Educator Excellence - Montclair State University

Click here to get full coverage on Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Average Rating of "Moderate Buy" by Analysts  MarketBeat

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Click here to get full coverage on NIA Small Business Showcase: Praxis Bioresearch - National Institute on Aging (.gov)

NIA Small Business Showcase: Praxis Bioresearch  National Institute on Aging (.gov)

NIA Small Business Showcase: Praxis Bioresearch - National Institute on Aging (.gov)

Click here to get full coverage on Praxis’ Vormatrigine Shows Significant Ability to Reduce Seizure Incidence in Phase 2 RADIANT Study - NeurologyLive

Praxis’ Vormatrigine Shows Significant Ability to Reduce Seizure Incidence in Phase 2 RADIANT Study  NeurologyLive

Praxis’ Vormatrigine Shows Significant Ability to Reduce Seizure Incidence in Phase 2 RADIANT Study - NeurologyLive

Click here to get full coverage on Praxis Precision Medicines stock maintains Overweight rating at Piper Sandler - Investing.com UK

Praxis Precision Medicines stock maintains Overweight rating at Piper Sandler  Investing.com UK

Praxis Precision Medicines stock maintains Overweight rating at Piper Sandler - Investing.com UK

Click here to get full coverage on Honors College Praxis Labs tackle real-world challenges - The University of Utah

Honors College Praxis Labs tackle real-world challenges  The University of Utah

Honors College Praxis Labs tackle real-world challenges - The University of Utah

Click here to get full coverage on PRAXIS, INC: 2025 - NYU Tisch School of the Arts

PRAXIS, INC: 2025  NYU Tisch School of the Arts

PRAXIS, INC: 2025 - NYU Tisch School of the Arts

Click here to get full coverage on Praxis AI pioneers AI-driven education with Claude in Amazon Bedrock - Anthropic

Praxis AI pioneers AI-driven education with Claude in Amazon Bedrock  Anthropic

Praxis AI pioneers AI-driven education with Claude in Amazon Bedrock - Anthropic

Click here to get full coverage on Democracy author to be featured in Praxis event in Sonoma - Sonoma Index-Tribune

Democracy author to be featured in Praxis event in Sonoma  Sonoma Index-Tribune

Democracy author to be featured in Praxis event in Sonoma - Sonoma Index-Tribune

Click here to get full coverage on Praxis links epilepsy drug to fall in seizures but sees 23% dropout rate - Fierce Biotech

Praxis links epilepsy drug to fall in seizures but sees 23% dropout rate  Fierce Biotech

Praxis links epilepsy drug to fall in seizures but sees 23% dropout rate - Fierce Biotech

Click here to get full coverage on AI leadership development platform Praxis Labs sells to Torch - TechCrunch

AI leadership development platform Praxis Labs sells to Torch  TechCrunch

AI leadership development platform Praxis Labs sells to Torch - TechCrunch

Click here to get full coverage on Praxis’ vormatrigine eliminates seizures in 22% of patients in Phase II trial - Clinical Trials Arena

Praxis’ vormatrigine eliminates seizures in 22% of patients in Phase II trial  Clinical Trials Arena

Praxis’ vormatrigine eliminates seizures in 22% of patients in Phase II trial - Clinical Trials Arena

Click here to get full coverage on From Near-Miss to Success: Praxis Bridge Advances Candidate Development and ETS's Vision for Education - PR Newswire

From Near-Miss to Success: Praxis Bridge Advances Candidate Development and ETS's Vision for Education  PR Newswire

From Near-Miss to Success: Praxis Bridge Advances Candidate Development and ETS's Vision for Education - PR Newswire

Click here to get full coverage on Officials defend law dropping test requirement for would-be teachers - New Jersey Monitor

Officials defend law dropping test requirement for would-be teachers  New Jersey Monitor

Officials defend law dropping test requirement for would-be teachers - New Jersey Monitor

Click here to get full coverage on Praxis Precision Medicines to Participate in September Investor Conferences - Yahoo Finance

Praxis Precision Medicines to Participate in September Investor Conferences  Yahoo Finance

Praxis Precision Medicines to Participate in September Investor Conferences - Yahoo Finance

Click here to get full coverage on What is Decolonial Praxis? - E-International Relations

What is Decolonial Praxis?  E-International Relations

What is Decolonial Praxis? - E-International Relations

Click here to get full coverage on Praxis Solutions Appoints John F. Sweeney as Chief Executive Officer - PR Newswire

Praxis Solutions Appoints John F. Sweeney as Chief Executive Officer  PR Newswire

Praxis Solutions Appoints John F. Sweeney as Chief Executive Officer - PR Newswire

Click here to get full coverage on Praxis gearing up to launch trial of relutrigine in Dravet, other DEEs - Dravet Syndrome News

Praxis gearing up to launch trial of relutrigine in Dravet, other DEEs  Dravet Syndrome News

Praxis gearing up to launch trial of relutrigine in Dravet, other DEEs - Dravet Syndrome News

Click here to get full coverage on Praxis shares pummeled after essential tremor trial falters - FirstWord Pharma

Praxis shares pummeled after essential tremor trial falters  FirstWord Pharma

Praxis shares pummeled after essential tremor trial falters - FirstWord Pharma

Click here to get full coverage on Praxis Precision Medicines (NASDAQ:PRAX) Stock Price Down 5.9% - What's Next? - MarketBeat

Praxis Precision Medicines (NASDAQ:PRAX) Stock Price Down 5.9% - What's Next?  MarketBeat

Praxis Precision Medicines (NASDAQ:PRAX) Stock Price Down 5.9% - What's Next? - MarketBeat

Click here to get full coverage on Praxis Launches Two Active Equity ETFs—PRXG and PRXV—for the ‘Heart of Your Portfolio’ - Business Wire

Praxis Launches Two Active Equity ETFs—PRXG and PRXV—for the ‘Heart of Your Portfolio’  Business Wire

Praxis Launches Two Active Equity ETFs—PRXG and PRXV—for the ‘Heart of Your Portfolio’ - Business Wire

Click here to get full coverage on Torch buys AI learning platform Praxis Labs to turn coaching into a strategic business lever - unleash.ai

Torch buys AI learning platform Praxis Labs to turn coaching into a strategic business lever  unleash.ai

Torch buys AI learning platform Praxis Labs to turn coaching into a strategic business lever - unleash.ai

Click here to get full coverage on Praxis Precision continues with ET trial despite likely failure warning - Clinical Trials Arena

Praxis Precision continues with ET trial despite likely failure warning  Clinical Trials Arena

Praxis Precision continues with ET trial despite likely failure warning - Clinical Trials Arena

Click here to get full coverage on South Korea’s Praxis Capital upsizes Fund IV target to USD 850m - ION Analytics

South Korea’s Praxis Capital upsizes Fund IV target to USD 850m  ION Analytics

South Korea’s Praxis Capital upsizes Fund IV target to USD 850m - ION Analytics

Click here to get full coverage on Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)  GlobeNewswire

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Click here to get full coverage on Praxis Precision Medicines Provides Update on Essential3 and Corporate Update - GlobeNewswire

Praxis Precision Medicines Provides Update on Essential3 and Corporate Update  GlobeNewswire

Praxis Precision Medicines Provides Update on Essential3 and Corporate Update - GlobeNewswire

Click here to get full coverage on Praxis Presses Forward in Essential Tremor Despite Futility Finding From Trial Observers - MedCity News

Praxis Presses Forward in Essential Tremor Despite Futility Finding From Trial Observers  MedCity News

Praxis Presses Forward in Essential Tremor Despite Futility Finding From Trial Observers - MedCity News

Click here to get full coverage on (PDF) Praxis and Poesis in Aristotle's practical philosophy - researchgate.net

(PDF) Praxis and Poesis in Aristotle's practical philosophy  researchgate.net

(PDF) Praxis and Poesis in Aristotle's practical philosophy - researchgate.net

Click here to get full coverage on Praxis’ Seizure Drug Demonstrates ‘Impressive’ Efficacy in Mid-Stage Trial - BioSpace

Praxis’ Seizure Drug Demonstrates ‘Impressive’ Efficacy in Mid-Stage Trial  BioSpace

Praxis’ Seizure Drug Demonstrates ‘Impressive’ Efficacy in Mid-Stage Trial - BioSpace

Click here to get full coverage on Sister Mary Scullion, RSM, Named 2025 Praxis Award Recipient for her Lifelong Service to Serving the Homeless - Villanova University

Sister Mary Scullion, RSM, Named 2025 Praxis Award Recipient for her Lifelong Service to Serving the Homeless  Villanova University

Sister Mary Scullion, RSM, Named 2025 Praxis Award Recipient for her Lifelong Service to Serving the Homeless - Villanova University

Click here to get full coverage on Expanding and mainstreaming sociohydrology toward transdisciplinary praxis - Frontiers

Expanding and mainstreaming sociohydrology toward transdisciplinary praxis  Frontiers

Expanding and mainstreaming sociohydrology toward transdisciplinary praxis - Frontiers

Click here to get full coverage on Praxis Lab: Equity, culture and preventive health - The University of Utah

Praxis Lab: Equity, culture and preventive health  The University of Utah

Praxis Lab: Equity, culture and preventive health - The University of Utah

Click here to get full coverage on Praxis Unveils New Folding Cog Gearbox - Sea Otter 2025 - Pinkbike

Praxis Unveils New Folding Cog Gearbox - Sea Otter 2025  Pinkbike

Praxis Unveils New Folding Cog Gearbox - Sea Otter 2025 - Pinkbike

Click here to get full coverage on Praxis Works Uses Hinged Gears to Create Unique Prototype HiT Transmission - Bikerumor

Praxis Works Uses Hinged Gears to Create Unique Prototype HiT Transmission  Bikerumor

Praxis Works Uses Hinged Gears to Create Unique Prototype HiT Transmission - Bikerumor

Click here to get full coverage on Praxis Launches ETF Suite With 2 New Faith-Based Funds - ETF Trends

Praxis Launches ETF Suite With 2 New Faith-Based Funds  ETF Trends

Praxis Launches ETF Suite With 2 New Faith-Based Funds - ETF Trends

Click here to get full coverage on Praxis Precision Medicines First Half 2025 Earnings: US$6.60 loss per share (vs US$4.58 loss in 1H 2024) - Yahoo Finance

Praxis Precision Medicines First Half 2025 Earnings: US$6.60 loss per share (vs US$4.58 loss in 1H 2024)  Yahoo Finance

Praxis Precision Medicines First Half 2025 Earnings: US$6.60 loss per share (vs US$4.58 loss in 1H 2024) - Yahoo Finance

Click here to get full coverage on Praxis touts 'best-in-disease' epilepsy data, but shares dip - FirstWord Pharma

Praxis touts 'best-in-disease' epilepsy data, but shares dip  FirstWord Pharma

Praxis touts 'best-in-disease' epilepsy data, but shares dip - FirstWord Pharma

Click here to get full coverage on Praxis hits trial setback; Bristol Myers lays off staff in New Jersey - BioPharma Dive

Praxis hits trial setback; Bristol Myers lays off staff in New Jersey  BioPharma Dive

Praxis hits trial setback; Bristol Myers lays off staff in New Jersey - BioPharma Dive

Click here to get full coverage on Praxis flouts phase 3 futility finding, forging ahead with tremor trial despite interim setback - Fierce Biotech

Praxis flouts phase 3 futility finding, forging ahead with tremor trial despite interim setback  Fierce Biotech

Praxis flouts phase 3 futility finding, forging ahead with tremor trial despite interim setback - Fierce Biotech

Click here to get full coverage on Altman-Backed Praxis Scouts Kyiv, Athens for Tech Utopia Base - Bloomberg.com

Altman-Backed Praxis Scouts Kyiv, Athens for Tech Utopia Base  Bloomberg.com

Altman-Backed Praxis Scouts Kyiv, Athens for Tech Utopia Base - Bloomberg.com

Click here to get full coverage on Praxis' Epilepsy Treatment Shows Promise With Decreased Seizures - Yahoo Finance

Praxis' Epilepsy Treatment Shows Promise With Decreased Seizures  Yahoo Finance

Praxis' Epilepsy Treatment Shows Promise With Decreased Seizures - Yahoo Finance

Click here to get full coverage on Praxis Precision Medicines to Host Conference Call to - GlobeNewswire

Praxis Precision Medicines to Host Conference Call to  GlobeNewswire

Praxis Precision Medicines to Host Conference Call to - GlobeNewswire

Click here to get full coverage on Praxis re-enters Jersey fund administration market - Asset Servicing Times

Praxis re-enters Jersey fund administration market  Asset Servicing Times

Praxis re-enters Jersey fund administration market - Asset Servicing Times

Click here to get full coverage on Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Relutrigine for the Treatment of Seizures Associated with SCN2A and SCN8A Developmental and Epileptic Encephalopathies - GlobeNewswire

Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Relutrigine for the Treatment of Seizures Associated with SCN2A and SCN8A Developmental and Epileptic Encephalopathies  GlobeNewswire

Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Relutrigine for the Treatment of Seizures Associated with SCN2A and SCN8A Developmental and Epileptic Encephalopathies - GlobeNewswire

Click here to get full coverage on Welcome to Praxis: The High-Tech, High-Testosterone Eden That Will Save the World - Vanity Fair

Welcome to Praxis: The High-Tech, High-Testosterone Eden That Will Save the World  Vanity Fair

Welcome to Praxis: The High-Tech, High-Testosterone Eden That Will Save the World - Vanity Fair

Click here to get full coverage on Praxis Medicines to Present at 36th International Epilepsy Congress 2025 in Lisbon, Showcasing Latest RADIANT Study Data and Leading Precision Epilepsy Pipeline - Yahoo Finance

Praxis Medicines to Present at 36th International Epilepsy Congress 2025 in Lisbon, Showcasing Latest RADIANT Study Data and Leading Precision Epilepsy Pipeline  Yahoo Finance

Praxis Medicines to Present at 36th International Epilepsy Congress 2025 in Lisbon, Showcasing Latest RADIANT Study Data and Leading Precision Epilepsy Pipeline - Yahoo Finance

Click here to get full coverage on News | Praxis completes major Scottish shopping centre acquisition - CoStar

News | Praxis completes major Scottish shopping centre acquisition  CoStar

News | Praxis completes major Scottish shopping centre acquisition - CoStar

Click here to get full coverage on Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2025 Financial Results - GlobeNewswire

Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2025 Financial Results  GlobeNewswire

Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2025 Financial Results - GlobeNewswire

Click here to get full coverage on We're Not Very Worried About Praxis Precision Medicines' (NASDAQ:PRAX) Cash Burn Rate - Yahoo Finance

We're Not Very Worried About Praxis Precision Medicines' (NASDAQ:PRAX) Cash Burn Rate  Yahoo Finance

Praxis Home Retail Limited (PRAXIS)

Price Chart

Key Statistics

Technicals

About PRAXIS

Latest News

Praxis Solutions Expands Leadership Team, Appoints Charlie Shaffer as Chief Revenue Officer to Lead Distribution Growth and AI-Powered Transformation - PR Newswire

Praxis Precision initiated with a Buy at JonesResearch - TipRanks

PRAXIS ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire

Advanced Charts

Top Gainers

Top Losers